Learn more about breast cancer screening and the importance of mammograms, featuring Dr. Anupama Acheson from Providence Cancer Institute.
Patients with hormone-receptor-positive, HER2-positive metastatic breast cancer may qualify for a newly opened clinical trial at Providence Cancer...
More than 200,000 women in the U.S. are diagnosed with breast cancer each year. Early detection is still key to help improve outcomes and finish cancer.
Dense breast tissue is normal. Half of women have dense tissue, a higher percentage of glandular and fibrous tissue in their breasts.
For women in their peak childbearing years, a breast cancer diagnosis and subsequent treatments can create fertility, pregnancy and breastfeeding challenges.
3D mammography, or Breast Tomosynthesis, provides a 3-D digital image of the breast, allowing for a more accurate view of some breast tissues.
The National Cancer Institute released a recent study which forecasts breast cancer cases will increase by 50 percent by 2030.
October is Breast Cancer Awareness Month. What motivates breast cancer patients to sign up for a research trial – is it hope or altruism or both?